Collector
Sun Pharma to acquire US drugmaker Organon in $11.75 billion all-cash deal | Collector
Sun Pharma to acquire US drugmaker Organon in $11.75 billion all-cash deal
Business Standard

Sun Pharma to acquire US drugmaker Organon in $11.75 billion all-cash deal

April 26 (Reuters) - India's Sun Pharmaceutical Industries ​will uy Organon & ​Co in an all-cash ‌deal, valuing the U.S. drugmaker at about $11.75 billion including ebt, the companies said on Sunday.

Go to News Site